PSMA; PSM-P1
PSMA/PSM-P1 (4-12) is a synthetic peptide fragment corresponding to amino acids 4 through 12 of the Prostate-Specific Membrane Antigen (PSMA), also known as Prostate-Specific Membrane Protein (PSM). As a well-defined peptide sequence derived from a clinically significant membrane glycoprotein, PSMA/PSM-P1 (4-12) is widely recognized for its utility in fundamental and translational research focused on prostate biology, oncology, and peptide-protein interaction studies. Its defined sequence and high specificity make it a valuable tool for investigating molecular mechanisms underlying PSMA function, as well as for developing and validating analytical assays targeting PSMA-related pathways.
Peptide binding studies: The PSMA/PSM-P1 (4-12) peptide serves as a model ligand for evaluating the binding affinity and specificity of antibodies, aptamers, or small molecules directed against the PSMA protein. Researchers can utilize this peptide fragment in surface plasmon resonance (SPR), enzyme-linked immunosorbent assays (ELISA), and other in vitro binding assays to characterize molecular interactions, optimize detection reagents, and assess the selectivity of PSMA-targeting agents. These studies are essential for the rational design of molecular probes and diagnostic tools in prostate cancer research.
Epitope mapping: As an epitope-mimetic peptide, PSMA/PSM-P1 (4-12) is instrumental in mapping the antigenic determinants recognized by monoclonal and polyclonal antibodies against PSMA. By providing a defined segment of the PSMA extracellular domain, the peptide allows for precise identification of antibody binding sites, facilitating the development and refinement of immunoassays. This application is particularly valuable in antibody engineering, where epitope mapping guides the selection and optimization of antibody candidates for research and diagnostic use.
Peptide-based assay development: The defined sequence of PSMA/PSM-P1 (4-12) enables its incorporation into custom assay platforms, such as competitive immunoassays or peptide microarrays, for the detection and quantification of PSMA or PSMA-reactive biomolecules. Its use in assay development supports the creation of sensitive and specific analytical methods for monitoring PSMA expression, screening for PSMA-binding compounds, or evaluating immune responses in preclinical research settings. The peptide's stability and compatibility with diverse detection systems enhance its versatility in assay optimization.
Structure-function analysis: By providing a discrete fragment of the PSMA protein, PSMA/PSM-P1 (4-12) allows researchers to dissect structure-function relationships within the PSMA extracellular domain. Investigations using this peptide can elucidate the contribution of specific amino acid residues to ligand binding, enzymatic activity, or protein-protein interactions. Such studies support the broader understanding of PSMA's biological roles and inform the rational design of targeted molecular interventions in prostate cancer and related fields.
Peptide synthesis and modification studies: PSMA/PSM-P1 (4-12) is frequently employed as a template in peptide synthesis research, enabling the evaluation of synthetic methodologies, labeling strategies, and post-synthetic modifications. Researchers can use this peptide for conjugation with fluorophores, biotin, or other functional moieties to generate labeled probes for imaging or detection applications. Additionally, the peptide serves as a benchmark for optimizing solid-phase peptide synthesis protocols and assessing the impact of sequence modifications on biochemical properties. In this context, it contributes to advancements in peptide chemistry and the development of novel peptide-based research tools.
2. Emu oil in combination with other active ingredients for treating skin imperfections
5. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More